| 1 |
35350513 | Comparative Study of the Effects of Azilsartan and Telmisartan on Insulin Resistance and Metabolic Biomarkers in Essential Hypertension Associated With Type 2 Diabetes Mellitus. | 2022 Feb |
1 |
| 2 |
34594226 | Telmisartan Potentiates Insulin Secretion via Ion Channels, Independent of the AT1 Receptor and PPARγ. | 2021 |
3 |
| 3 |
31146668 | Hypertension in Polycystic Ovary Syndrome: Novel Insights. | 2020 |
1 |
| 4 |
30688550 | Even Short-Term Telmisartan Treatment Ameliorated Insulin Resistance But Had No Influence on Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels in Hypertensive Patients with Metabolic Syndrome. | 2019 Apr |
3 |
| 5 |
29399098 | Effects of telmisartan on vascular endothelial function, inflammation and insulin resistance in patients with coronary heart disease and diabetes mellitus. | 2018 Jan |
1 |
| 6 |
29466880 | Telmisartan reverses antiretroviral-induced adipocyte toxicity and insulin resistance in vitro. | 2018 May |
1 |
| 7 |
25994603 | Comparison of the effects of barnidipine+losartan compared with telmisartan+hydrochlorothiazide on several parameters of insulin sensitivity in patients with hypertension and type 2 diabetes mellitus. | 2015 Oct |
1 |
| 8 |
26474943 | Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy. | 2015 Oct 15 |
5 |
| 9 |
24786779 | Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study. | 2014 Dec |
1 |
| 10 |
25151319 | A meta-analysis of randomized trials of telmisartan versus active controls for insulin resistance in hypertensive patients. | 2014 Aug |
5 |
| 11 |
22561230 | The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO). | 2013 Jan |
1 |
| 12 |
21848583 | Systematic review of the effect of telmisartan on insulin sensitivity in hypertensive patients with insulin resistance or diabetes. | 2012 Jun |
6 |
| 13 |
22193374 | Optimization of comorbidity therapy to achieve sustained viral response in HCV patients. | 2012 Jul-Aug |
1 |
| 14 |
22378488 | Telmisartan improves cardiometabolic profile in obese patients with arterial hypertension. | 2012 |
2 |
| 15 |
22429010 | Telmisartan in the management of diabetic nephropathy: a contemporary view. | 2012 May |
2 |
| 16 |
22812514 | Relationship between telmisartan dose and glycaemic control in Japanese patients with type 2 diabetes mellitus and hypertension: a retrospective study. | 2012 Sep 1 |
1 |
| 17 |
22821644 | Telmisartan at 80 mg/day increases high-molecular-weight adiponectin levels and improves insulin resistance in diabetic patients. | 2012 Jul |
2 |
| 18 |
23137106 | Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice. | 2012 Nov 8 |
2 |
| 19 |
21245772 | Telmisartan improves insulin resistance in patients with low cytokine levels. | 2011 Mar |
3 |
| 20 |
21269058 | Telmisartan lowers home blood pressure and improves insulin resistance without correlation between their changes. | 2011 |
2 |
| 21 |
21514293 | Telmisartan increases localization of glucose transporter 4 to the plasma membrane and increases glucose uptake via peroxisome proliferator-activated receptor γ in 3T3-L1 adipocytes. | 2011 Jun 25 |
9 |
| 22 |
21744143 | Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE). | 2011 Aug |
4 |
| 23 |
21817185 | Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients. | 2011 |
1 |
| 24 |
22008920 | Effects of telmisartan on insulin resistance and visceral fat distribution in Chinese hypertensive patients with obesity. | 2011 Oct |
1 |
| 25 |
22077832 | Telmisartan: just an antihypertensive agent? A literature review. | 2011 Dec |
1 |
| 26 |
24331136 | Telmisartan effectively improves insulin sensitivity in hypertensive patients with insulin resistance. | 2011 Oct-Dec |
6 |
| 27 |
20056982 | Angiotensin receptor blocker telmisartan improves insulin sensitivity in peritoneal dialysis patients. | 2010 Jan-Feb |
4 |
| 28 |
20388049 | Alterations of insulin resistance and the serum adiponectin level in patients with type 2 diabetes mellitus under the usual antihypertensive dosage of telmisartan treatment. | 2010 May |
5 |
| 29 |
20449538 | Effects of telmisartan vs olmesartan on metabolic parameters, insulin resistance and adipocytokines in hypertensive obese patients. | 2010 Mar-Apr |
2 |
| 30 |
20467177 | The insulin sparing effect of telmisartan in a case of type 2 diabetes mellitus associated with schizophrenia under treatment of risperidone. | 2010 |
1 |
| 31 |
20493430 | Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus. | 2010 Jun |
1 |
| 32 |
20630944 | Effect of telmisartan on selected adipokines, insulin sensitivity, and substrate utilization during insulin-stimulated conditions in patients with metabolic syndrome and impaired fasting glucose. | 2010 Oct |
2 |
| 33 |
20823643 | Effects of telmisartan on insulin resistance in Japanese type 2 diabetic patients. | 2010 |
2 |
| 34 |
20883237 | Telmisartan effects on insulin resistance in obese or overweight adults without diabetes or hypertension. | 2010 Sep |
2 |
| 35 |
25649195 | Open-label, Randomized Crossover Study Between Telmisartan and Valsartan on Improving Insulin Resistance and Adipocytokines in Nondiabetic Patients with Mild Hypertension. | 2010 |
1 |
| 36 |
19248193 | Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis. | 2009 Feb 28 |
1 |
| 37 |
19708000 | Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients. | 2009 Dec |
3 |
| 38 |
19822103 | Beneficial effects of telmisartan in an HIV+ diabetic insulin-dependent patient. | 2009 Jul-Sep |
1 |
| 39 |
19922882 | Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease. | 2009 Oct |
1 |
| 40 |
17884270 | Telmisartan, an angiotensin II type-1 receptor blocker, improved insulin resistance in a schizophrenic patient treated with olanzapine: a case report. | 2008 Jan 1 |
1 |
| 41 |
18327991 | Treatment of hypertension in individuals with the cardiometabolic syndrome: role of an angiotensin II receptor blocker, telmisartan. | 2008 Mar |
1 |
| 42 |
18380932 | Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-elicited hepatic insulin resistance via peroxisome proliferator-activated receptor-gamma activation. | 2008 Mar-Apr |
4 |
| 43 |
18633172 | Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy. | 2008 Apr |
2 |
| 44 |
18692932 | The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control. | 2008 Oct |
2 |
| 45 |
18792876 | Possible molecular mechanisms by which angiotensin II type 1 receptor blockers (ARBs) prevent the development of atrial fibrillation in insulin resistant patients. | 2008 Sep |
1 |
| 46 |
18813860 | Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study. | 2008 Oct |
3 |
| 47 |
19008718 | Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives. | 2008 Dec |
4 |
| 48 |
17351377 | Effects of telmisartan on fat distribution in individuals with the metabolic syndrome. | 2007 Apr |
1 |
| 49 |
17460371 | Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome. | 2007 Jan |
1 |
| 50 |
17526471 | Telmisartan improves lipid metabolism and adiponectin production but does not affect glycemic control in hypertensive patients with type 2 diabetes. | 2007 Jan-Feb |
1 |